期刊文献+

耐药性癫患者的载脂蛋白E(ApoE)基因多态性分析 被引量:1

The ApoE gene polymorphism of drug resistant epilepsy patients
原文传递
导出
摘要 目的研究耐药性癫患者的载脂蛋白E基因多态性,并探究影响耐药性癫形成机制的遗传因素。方法取耐药性癫患者肘静脉血,用PCR-RFLP技术检测ApoE基因多态性,并与非耐药性癫和正常对照组进行比较分析。结果耐药性癫组中ε4等位基因的频率为(16.9)),明显高于非耐药性癫组(8.2)和正常对照组,其差异有统计学意义(P<0.05),而ε2,ε3等位基因的频率三组之间差异无统计学意义(P>0.05);病例组与正常对照组ApoE基因多态性有显著性差异(P<0.01)。结论ApoEε4等位基因可增加耐药性癫发生的危险性。 Objective To study the relationship between ApoE gene polymorphism and drug resistant epilepsy, and to investigate the mechanism of drug resistant epilepsy in genetics. Methods The polymorphism of ApoE gene was detected by using PCR-RFLP technique. Results The frequency of ApoEε4 allele in drug resistant epilepsy cases, non-drug resistant contrast and normal contrast was 16. 9%, 8. 2% and 9. 0% respectively. There was statistic difference in the three (P〈0. 05) , but no statistic difference (P〉0.05) of ε2,ε3 allele frequency in the three. There was significant difference of ApoE gene polymorphism between drug resistant epilepsy cases and contrast. Conclusions ApoEε4 genotype can increase the risk of drug resistant epilepsy.
出处 《卒中与神经疾病》 2008年第2期103-105,共3页 Stroke and Nervous Diseases
关键词 载脂蛋白E 基因多态性 耐药性癫癎 Apolipopprotein E gene polymorphism drug resistant epolepsy
  • 相关文献

参考文献12

  • 1Ignatius MJ, Gebicke-Harter PJ, Skene JHP, et al. Expression of apolipoprotein E during nerve degeneration and regeneration. Proc Natl Acad Sci USA, 1986,83(4) : 1125-1129.
  • 2陈煜森,许志恩,赵斌,山县英久,三木哲郎.ApoE基因多态性与阿尔茨海默病的相关性研究[J].神经疾病与精神卫生,2006,6(2):89-91. 被引量:9
  • 3钱采韻.阿尔茨海默病的血管因素研究[J].中国神经精神疾病杂志,2002,28(6):475-476. 被引量:10
  • 4Diaz-Arrastia R, Gong Y, Fair S, et al. Increased risk of late posttraumatic seizures associated with inheritance of APOE epsilon4 allele. Arch Neurlo,2003, 60(6) :818-822.
  • 5陈文珍,郑锦志.颞叶癫痫的遗传学[J].国外医学(神经病学.神经外科学分册),2004,31(3):273-275. 被引量:1
  • 6Briellmann R. S, Torn-Broers Y, Busuttil B. E, et al. ApoFat4 genotype is associated with an earlier onset of chronic temporal lobe epilepsy. Neurology, 2000,55(3) :435-437.
  • 7McDowell IF, Wisdom Gb, Trimble ER. Apolipoprotein E phenotype determined by agarose gel electrofocusing and immunoblotting. Clin Chem, 1989,35(10):2070-2073.
  • 8Mahley RW. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science, 1988, 240(4852): 622-630.
  • 9张莉莉,吕安林,王海昌,贾国良.载脂蛋白E基因多态性与冠心病相关因素的关联性[J].心脏杂志,2004,16(3):252-254. 被引量:9
  • 10Lahoz C, Schaefer EJ, Cupples LA, et al. Apolipoprotein E genotype and cardiovascular disease in the Framingham Heart Study. Atherselerosis,2001,154(3) :529.

二级参考文献53

  • 1[1]Shi J, Perry G, Smith MA, et al. Vascular abnormalities: the insidious pathogenesis of Alzheimer's disease. Neurobiology of Aging, 2000, 21 (2) :375.
  • 2[2]Kudo T, Imaizumi K, Tanimukai H, et al. Are cerebrovascular factor involved in Alzheimer's disease? Neurobiology of aging, 2000,21 (2): 215.
  • 3[3]M.M.B Breteler. Vascular risk factors for Alzheimers disease: An epidemiology perspective. Neurobiology of Aging, 2000,21 (2): 153.
  • 4[4]Launer L J, White LR, Petrovitch H, et al. Cholesterol and neuropathologic markers of AD. Neurology, 2001,57(8): 1147.
  • 5[5]Shalden MF, Larson EB, Yukawa M. The epidemiology of Alzheimer's disease and vascular dementia in Japanese and Africian-Americian populations: the search for etiological clues. Neurobiology of Aging, 2000,21(2):171.
  • 6[6]Kalaria RN. The role of cerebral ischemia in Alzheimer's disease. Neurobiology of Aging, 2000,21(2) :321.
  • 7[7]Meyer JS, Rauch G, Rauch RA, et al. Risk factors for cerebral hypoperfusion, mild cognitive impairment, and dementia. Neurobiology of Aging,2000,21(2): 161.
  • 8[8]Hirono N, Kitagaki H, Kazui H, et al. Impact of white matter changes on clinical manifestation of Alzheimer's disease: A quantitative study.Stroke, 2000,31(9) :2182.
  • 9[9]Johonson KA, Albert MS. Perfudion abnormalities in prodromal AD. Neurobiology of Aging, 2000,21(2) :289.
  • 10[10]Ni J, Ohta H, Matsumoto K, et al. Progressive congnitive impairmentfollowing chronic cerebral hypoperfusion induced by permanent occlusion of bilateral carotid arteries in rats. Brain Research, 1994,653( 1 -2):231.

共引文献25

同被引文献20

  • 1MAHLEY R W. Apolipoprotein E : cholesterol transport protein with expanding role in cell biology [ J ] , Science, 1988,240 (4852) : 622-630.
  • 2RALL S C J R,WEISGRABER K H,MAHLEY R W. Human apo- lipoprotein E. The complete amino acid sequence [ J ]. J Blot Chem, 1982,257 (8) :4171-4178.
  • 3DASH K, MCPHERSON J, BRUNS G A, et al. Isolation, charac- terization, and mapping to chromosome 19 of the human apolipopro- tein E gene[ J]. J Biol Chem, 1985,260(10) :6240-6247.
  • 4XU P T, GILBERT J R, QIU H L, et al. Specific regional transcrip- tion of apolipoprotein E in human brain neurons[ J]. Am J Pathol, 1999,154(2) :601-611.
  • 5WEISGRABER K H, NEWHOUSE Y M, MAHLEY R W. Apoli- poprotein E genotyping using the polymerase chain reaction and al- lele-specific oligonucleotide probes [ J ] . Biochem Biophys Res Commun, 1988,157 ( 3 ) : 1212-1217.
  • 6ZANNIS V I. Genetic polymorphism in human apolipoprotein E [ J]. Methods Enzymol, 1986,128:823-851.
  • 7MANELLI A M, STINE W B, VAN ELDIK L J,et al. ApoE and Abetal-42 interactions: effects of isoform and conformation on structure and function [ J ]. J Mol Neurosci,2004,23 ( 3 ) :235-246.
  • 8STRITTMATTER W j, SAUNDERS A M, SCHMECHEL D,et al. Apolipoprotein E:high-avidity binding to beta-amyloid and in- creased frequency of type 4 allele in late-onset familial Alzheimer disease[ J]. Proc Natl Acad Sci USA, 1993,90 ( 5 ) : 1977-1981.
  • 9MERCIER G, LUCOTTE G. Apolipoprotein E epsilon 4 allele, the major risk factor for Alzheimer's disease,is also involved in tempo- ral lobe epilepsy [ J ]. Alzheimers Reports, 2000,3 ( 545 ) : 265-268.
  • 10BRIELLMANN R S, TORN-BROERS Y, BUSUTTIL B E, et al. APOE epsilon4 genotype is associated with an earlier onset of chronic temporal lobe epilepsy [ J ]. Neurology, 2000,55 ( 3 ) : 435- 437.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部